Diabetic neuropathy is a degenerative complication of diabetes accompanied by an alteration of nerve conduction velocity and Na,K-ATPase activity. This decrease in Na,KATPase activity has been implicated in the pathogenesis of electrophysiological abnormalities characterizing neuropathic complication in different animal models and in humans (1). Na,K-ATPase is a membrane-bound enzyme consisting of three catalytic isoenzymes (~1, ct2, ~3) and a large lipid core (2). It plays a fundamental rote in Na + and K + transport by maintaining the ionic gradients necessary for nervous excitability. A decrease in this process leads to an increase in the intracellular concentration of sodium and a corresponding decrease in membrane sodium potential. The mechanism responsible for impairment of Na,K-ATPase during hyperglycemia is still uncleal, but alterations of the kinetic parameters of the enzyme and/or of subunit expression are likely (3,4). In recent years there has been great interest in the effect of n-3 essential fatty acids, found particularly in fish oil, on the prevention of atherosclerosis and hypertension in animal models and patients with vascular disease (5). Fish oil treatment as MaxEPA was recently reported to improve vascular function in diabetic patients (6), and prevent c~2 isoenzyme activity of Na, K-ATPase in diabetic cardiomyopathy (7). Aim o f the study. The present study in rats was designed, first, to measure diabetes-induced abnormalities in Na,KATPase acyivity, isoenzyme expression, fatty acid content in sciatic membranes, and nerve conduction velocity and second, to assess the preventive ability of a fish-oil rich diet (rich in n-3 fatty acids) on these abnormalities. Methods. Diabetes was induced by intravenous streptozotocin injection. Diabetic animals (D) and nondiabetic control animals (C) were fed the standard rat chow either without supplementation or supplemented with either fish oil (DM, CM) or olive oil (DO, CO) at a daily dose of 0.5 g/kg by gavage during 8 wk.
Read full abstract